Volumetric Modulated Arc Therapy and Conventional Intensity-modulated Radiotherapy for Simultaneous Maximal Intraprostatic Boost: a Planning Comparison Study

Clinical Oncology

Volumn 21, Issue 5, 2009, Pages 401-407

  Shaffer, R ^a,b   Morris, W J ^a   Moiseenko, V ^a   Welsh, M ^a   Crumley, C ^a   Nakano, S ^a   Schmuland, M ^a   Pickles, T ^a   Otto, K ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Boost; IMRT; prostate cancer; radiotherapy; VMAT

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; TREATMENT PLANNING; TUMOR VOLUME; VOLUMETRIC MODULATED ARC THERAPY;

DOSE FRACTIONATION; HUMANS; MALE; MATCHED-PAIR ANALYSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 67349203540     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.01.014     Document Type: Article

References (35)

1. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32 (1995) 3-12
2. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
3. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 1 (2008) 67-74
4. Al-Mamgani A., van Putten W.L., Heemsbergen W.D., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 73 (2008) 980-988
5. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
6. Gardner B.G., Zietman A.L., Shipley W.U., Skowronski U.E., and McManus P. Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 167 (2002) 123-126
7. Zelefsky M.J., Yamada Y., Fuks Z., et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71 (2008) 1028-1033
8. Eade T.N., Hanlon A.L., Horwitz E.M., Buyyounouski M.K., Hanks G.E., and Pollack A. What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 682-689
9. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 16 (2002) 196-200
10. Pickles M.D., Gibbs P., Sreenivas M., and Turnbull L.W. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging 23 (2006) 130-134
11. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
12. Zelefsky M.J., Cohen G., Zakian K.L., et al. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J 6 (2000) 249-255
13. Singh A.K., Guion P., Sears-Crouse N., et al. Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study. Radiat Oncol 2 (2007) 36
14. Kurhanewicz J., Vigneron D., Carroll P., and Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 18 (2008) 71-77
15. Chen M.E., Johnston D.A., Tang K., Babaian R.J., and Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89 (2000) 1800-1809
16. Byar D.P., and Mostofi F.K. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30 (1972) 5-13
17. De Meerleer G.O., Vakaet L.A., De Gersem W.R., De Wagter C., De Naeyer B., and De Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 47 (2000) 639-648
18. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 35 (2008) 310-317
19. Palma D., Vollans E., James K., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 996-1001
20. Otto K., Milette M., and Wu J. Temporal delivery efficiency of a novel single gantry arc optimization technique for treatment of recurrent nasopharynx cancer. Int J Radiat Oncol Biol Phys 69 3 Suppl (2007) S703
21. Cozzi L., Dinshaw K.A., Shrivastava S.K., et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89 (2008) 180-191
22. Morris W. ASCENDE-RT: androgen suppression combined with elective nodal and dose escalated radiation therapy. Available from:. http://clinicaltrials.gov/show/NCT00175396
23. Bucci J., Spadinger I., Hilts M., et al. Urethral and periurethral dosimetry in prostate brachytherapy: is there a convenient surrogate?. Int J Radiat Oncol Biol Phys 54 (2002) 1235-1242
24. Storchi P.R., van Battum L.J., and Woudstra E. Calculation of a pencil beam kernel from measured photon beam data. Phys Med Biol 44 (1999) 2917-2928
25. Stein J., Mohan R., Wang X.H., et al. Number and orientations of beams in intensity-modulated radiation treatments. Med Phys 24 (1997) 149-160
26. Akimoto T., Katoh H., Noda S.E., et al. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 63 (2005) 472-478
27. Thomas C., Keyes M., Liu M., and Moravan V. Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 72 (2008) 447-455
28. Lee W.R. RTOG 0415 Trial: radiation therapy in treating patients with stage II prostate cancer. Available from:. http://clinicaltrials.gov/show/NCT00175396
29. van der Wielen G.J., Hoogeman M.S., Dohle G.R., van Putten W.L., and Incrocci L. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial. Int J Radiat Oncol Biol Phys 71 (2008) 795-800
30. van der Wielen G.J., Mulhall J.P., and Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 84 (2007) 107-113
31. Macdonald A.G., Keyes M., Kruk A., Duncan G., Moravan V., and Morris W.J. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?. Int J Radiat Oncol Biol Phys 63 (2005) 155-163
32. Davis B.J., Pisansky T.M., Wilson T.M., et al. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Cancer 85 (1999) 2630-2637
33. Sohayda C., Kupelian P.A., Levin H.S., and Klein E.A. Extent of extracapsular extension in localized prostate cancer. Urology 55 (2000) 382-386
34. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
35. Willoughby T.R., Kupelian P.A., Pouliot J., et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 65 (2006) 528-534